Also known as آسٹیوپوروسس مینجمنٹ
Internal Medicine Specialist
MBBS, FCPS (Medicine)
Diabetologist
M.B.B.S, M.P.H., M.C.P.S
Internal Medicine Specialist
MBBS, MARH (UK), MCPS, MRCGP (UK), FRCGP (UK)
Internal Medicine Specialist
MBBS, MARH (UK), MCPS, MRCGP (UK), FRCGP (UK)
Rheumatologist
MBBS, FCPS (MEDICINE), FCPS (RHEUMATOLOGY)
Internal Medicine Specialist
MBBS, MRCP (UK)
Consultant Physician
M.B.B.S., FCPS (Medicine), FCPS (Pulmonology), FRCP
Consultant Physician
M.B.B.S., FCPS (Medicine), FCPS (Pulmonology), FRCP
Gastroenterologist
MBBS, FCPS (Gastroenterology), ESEGH (Gastroenterology & Hepatology)
Gastroenterologist
MBBS, FCPS (Gastroenterology), ESEGH (Gastroenterology & Hepatology)
Internal Medicine Specialist
MBBS, FCPS
Internal Medicine Specialist
M.B.B.S, F.C.P.S
Nephrologist
FRCP (Edinburgh,UK), FRCP (Ireland), MRCPS (Glasgow,UK), MRCP (Ireland), FCPS (Nephrology), FCPS (Medicine), Diplomate and Affiliate American Board of Regenerative Medicine (DABRM) , MBBS (KMU), FRCP ( Glasgow, UK)
Nephrologist
FRCP (Edinburgh,UK), FRCP (Ireland), MRCPS (Glasgow,UK), MRCP (Ireland), FCPS (Nephrology), FCPS (Medicine), Diplomate and Affiliate American Board of Regenerative Medicine (DABRM) , MBBS (KMU), FRCP ( Glasgow, UK)
Bisphosphonates are used as first-line pharmacologictreatment for osteoporosis. In patients who cannot tolerate or whose symptoms do not improve with bisphosphonate therapy, teriparatide (Forteo) and denosumab (Prolia) are effective alternative medications to prevent osteoporotic fractures